(ABL) Abacus Life - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US00258Y1047
ABL: Life Insurance, Policy Services, Investment Products
Abacus Life, Inc. operates as an alternative asset manager and market maker in the United States. It operates through three segments: Portfolio Servicing, Active Management, and Originations. The Portfolio Servicing segment provides policy services to customers on a contract basis. The Active Management segment is involved in buying, selling, and trading policies, as well as maintaining policies until receipt of death benefits. The Originations segment originates life insurance policy settlements between investors or buyers, and the sellers, who is often the original policy owner. The company sells its products through financial advisor or agent, direct to consumer, and traditional life settlements intermediaries. Abacus Life, Inc. was founded in 2004 and is headquartered in Orlando, Florida. Web URL: https://abacuslife.com
Additional Sources for ABL Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ABL Stock Overview
Market Cap in USD | 735m |
Sector | Financial Services |
Industry | Insurance - Life |
GiC Sub-Industry | Insurance Brokers |
IPO / Inception | 2020-09-14 |
ABL Stock Ratings
Growth 5y | -42.4% |
Fundamental | -15.0% |
Dividend | - |
Rel. Strength Industry | -208 |
Analysts | 4.75/5 |
Fair Price Momentum | 6.48 USD |
Fair Price DCF | - |
ABL Dividends
No Dividends PaidABL Growth Ratios
Growth Correlation 3m | -90.1% |
Growth Correlation 12m | -89.8% |
Growth Correlation 5y | 4.7% |
CAGR 5y | -5.85% |
CAGR/Mean DD 5y | -0.51 |
Sharpe Ratio 12m | -0.62 |
Alpha | -46.46 |
Beta | 0.19 |
Volatility | 47.72% |
Current Volume | 204.2k |
Average Volume 20d | 226.8k |
What is the price of ABL stocks?
As of January 22, 2025, the stock is trading at USD 7.52 with a total of 204,220 shares traded.
Over the past week, the price has changed by +1.62%, over one month by -3.59%, over three months by -21.17% and over the past year by -37.90%.
As of January 22, 2025, the stock is trading at USD 7.52 with a total of 204,220 shares traded.
Over the past week, the price has changed by +1.62%, over one month by -3.59%, over three months by -21.17% and over the past year by -37.90%.
Is Abacus Life a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Abacus Life is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -14.97 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ABL as of January 2025 is 6.48. This means that ABL is currently overvalued and has a potential downside of -13.83%.
Neither. Based on ValueRay Fundamental Analyses, Abacus Life is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -14.97 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ABL as of January 2025 is 6.48. This means that ABL is currently overvalued and has a potential downside of -13.83%.
Is ABL a buy, sell or hold?
Abacus Life has received a consensus analysts rating of 4.75. Therefor, it is recommend to buy ABL.
Abacus Life has received a consensus analysts rating of 4.75. Therefor, it is recommend to buy ABL.
- Strong Buy: 3
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecast for ABL stock price target?
According to ValueRays Forecast Model, ABL Abacus Life will be worth about 7 in January 2026. The stock is currently trading at 7.52. This means that the stock has a potential downside of -7.05%.
According to ValueRays Forecast Model, ABL Abacus Life will be worth about 7 in January 2026. The stock is currently trading at 7.52. This means that the stock has a potential downside of -7.05%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 14.4 | 91.2% |
Analysts Target Price | 14.4 | 91.2% |
ValueRay Target Price | 7 | -7% |